Answers are grounded in this paper and cite their sources.
Extracellular vesicles (EVs) carry heterogeneous protein and glycan signatures, but their nanoscale size limits direct single particle analysis by conventional flow cytometry. Here, we developed an EV surface-confined reversible addition−fragmentation chain-transfer polymerization strategy, termed EV-RAFT, to enlarge individual EVs while preserving their surface molecular information. A cholesterol-chain transfer agent conjugate was inserted into the EV membrane, followed by visible-light-induced acrylamide polymerization using eosin Y and triethanolamine. The resulting polymer layer increased EV size and enabled their detection by conventional flow cytometry. To analyze glycans associated with specific membrane proteins, we further introduced an aptamer−lectin proximity recognition system. Protein-targeting aptamers and glycan-binding lectins were linked to complementary DNA probes, allowing fluorescent reporter assembly only when the selected protein and glycan were spatially adjacent. A seven-lectin panel was used to generate protein-specific glycan fingerprints of CD33-and nucleolin-positive EVs derived from THP-1 and HL-60 cells. Distinct glycan patterns were observed among different cell origins and protein sites. The platform also differentiated EV glycan signatures in plasma samples from patients with acute myeloid leukemia and healthy controls. EV-RAFT provides an accessible approach for multidimensional single-EV phenotyping using conventional flow cytometry.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: